Tel Aviv University scientists have shown that oxygen chamber treatment can have positive effects on Alzheimer-affected brain tissue.

A new discovery by Israeli and American researchers seeks to effectively screen and diagnose Alzheimer's through simple blood tests.

Tel Aviv University professor has uncovered a protein that may protect brain cells from harm by dementia-based diseases, such as Alzheimer's and Parkinson's.

A new study from Tel Aviv University may be one of the most important discoveries in the field of neurodegenerative disease. Researchers found that a phenomenon thought to be the cause of Huntington's disease is actually one of the body's defense mechanism.

This year's winner of the Israel Prize for Medicine is professor Marta Weinstock-Rosin, who developed the first and only FDA-approved skin patch to treat dementia caused by Alzheimer's disease.

Studies show that many people who serve as caretakers for family members suffering from Alzheimer's disease are prone to depression. A new Israeli study has found that the cure for such depression could come in the form of practicing art.

As the human brain gets older, it is increasingly prone to neurodegenerative disease. If only it were possible to simply stop the brain from aging. As it turns out, it might just be, as recent study by Hebrew University researchers and an Israeli startup has shown.

With no known cure, Alzheimer's Disease is still the most common form of dementia and a leading cause of death among people 65 and older. Now, a team of Israeli researchers have made progress with a finding that may help diagnose the disease as early as at the age of 30, and treat it accordingly.

Neuronix has developed what may be the most advanced non-invasive treatment for Alzheimer's Disease. The company says its treatment can restore a patient's cognitive ability to a state comparable to that of two years before treatment.

Despite many medical advances, there is currently still no effective way to stop the progression of neurodegenerative diseases such as Alzheimer's or Parkinson's. Now, an Israeli research team may have discovered something that can stop the progress of these diseases.

As more information is gathered on Alzheimer's disease, it is now accepted that a protein called amyloid-beta has a key role in the disease's progression. New research done in Tel Aviv uses electricity to balance the protein's levels in the brain.

When it comes to neurodegenerative disease, much remains in the dark. However, step by step, science is getting closer the causes of these diseases and how to treat them. Another such step was made by Israeli researchers recently.

Neurodegenerative diseases, such as Alzheimer's and ALS, are almost impossible to predict before symptoms appear. Israeli company NeuroQuest may be able to predict these diseases with its much-anticipated technology based on biomarker measurement.

A new understanding of what takes place at the cellular level during the development of neurodegenerative diseases, such as Parkinson’s and Alzheimer’s offers promise towards possible new treatments, according to the Hebrew University.

Detecting early- stage Alzheimer's disease may be as easy as a simple blood test, a new study at Tel Aviv University suggests. The scientists found that the test may be up to 90 percent accurate in predicting the disease.